The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.It should be noted that the reported patient effect of prolapse is listed in the xience sierra, everolimus eluting coronary stent system instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
Patient id: (b)(6).It was reported that on (b)(6) 2020, a percutaneous coronary intervention (pci) was performed on the proximal circumflex (cx) coronary artery, 80% stenosed lesion.A 3.0x18mm xience sierra stent was implanted in the cx and post-dilatation performed.Post-procedure there was timi flow iii and 0% residual stenosis.Following, plaque shift occurred.As treatment, additional balloon angioplasty was performed.Elevated cardiac enzymes were also noted post-procedure.There was no diagnosed myocardial infarction and there was no additional treatment provided.The event resolved without sequela.No additional information was provided regarding this issue.
|